Paper41511706
Immune-microbiota crosstalk in colorectal cancer: mechanistic pathways, biomarkers, and translational therapeutics.
Shekar P and 4 others. Clin Transl Oncol, 2026. Cited by 2 papers, by iCite.
Cite this record
ConductScience Library. Immune-microbiota crosstalk in colorectal cancer: mechanistic pathways, biomarkers, and translational therapeutics. Papers, record 41511706. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41511706
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Immune-microbiota crosstalk in colorectal cancer: mechanistic pathways, biomarkers, and translational therapeutics.
- PubMed
Topics8
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Colorectal Neoplasms | Major topic |
| Gastrointestinal Microbiome | Major topic |
| Humans | |
| Biomarkers, Tumor | |
| Translational Research, Biomedical | |
| Probiotics | |
| Fecal Microbiota Transplantation | |
| Animals |
Source PubMed
References71
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 23831042 | Faecalibacterium prausnitzii and human intestinal health. | Curr Opin Microbiol | 2013 | https://conductscience.org/library/papers/23831042 | PubMed |
| 2 | 33125859 | The Challenges of Tumor Mutational Burden as an Immunotherapy Biomarker. | Cancer Cell | 2021 | https://conductscience.org/library/papers/33125859 | PubMed |
| 3 | 36426359 | Effects of gut microbiota on immune responses and immunotherapy in colorectal cancer. | Front Immunol | 2022 | https://conductscience.org/library/papers/36426359 | PubMed |
| 4 | 21205640 | Induction of colonic regulatory T cells by indigenous Clostridium species. | Science | 2011 | https://conductscience.org/library/papers/21205640 | PubMed |
| 5 | 38903520 | The role of the gut microbiota in tumor, immunity, and immunotherapy. | Front Immunol | 2024 | https://conductscience.org/library/papers/38903520 | PubMed |
| 6 | 17275323 | TLR signaling. | Semin Immunol | 2007 | https://conductscience.org/library/papers/17275323 | PubMed |
| 7 | 37624549 | Exploring the complex role of gut microbiome in the development of precision medicine strategies for targeting microbial imbalance-induced colon cancer. | Folia Microbiol (Praha) | 2023 | https://conductscience.org/library/papers/37624549 | PubMed |
| 8 | 34884543 | The Role of the Immune System in IBD-Associated Colorectal Cancer: From Pro to Anti-Tumorigenic Mechanisms. | Int J Mol Sci | 2021 | https://conductscience.org/library/papers/34884543 | PubMed |
| 9 | 33303685 | Fecal microbiota transplant promotes response in immunotherapy-refractory melanoma patients. | Science | 2021 | https://conductscience.org/library/papers/33303685 | PubMed |
| 10 | 35816968 | Microbial mechanisms to improve immune checkpoint blockade responsiveness. | Neoplasia | 2022 | https://conductscience.org/library/papers/35816968 | PubMed |
| 11 | 33802045 | Microbial Metabolites in Colorectal Cancer: Basic and Clinical Implications. | Metabolites | 2021 | https://conductscience.org/library/papers/33802045 | PubMed |
| 12 | 30857316 | Prebiotics: Definition, Types, Sources, Mechanisms, and Clinical Applications. | Foods | 2019 | https://conductscience.org/library/papers/30857316 | PubMed |
| 13 | 35048197 | Genomic landscape of colorectal carcinogenesis. | J Cancer Res Clin Oncol | 2022 | https://conductscience.org/library/papers/35048197 | PubMed |
| 14 | 18692464 | TGF-beta: a master of all T cell trades. | Cell | 2008 | https://conductscience.org/library/papers/18692464 | PubMed |
| 15 | 28967885 | Assessment of variation in microbial community amplicon sequencing by the Microbiome Quality Control (MBQC) project consortium. | Nat Biotechnol | 2017 | https://conductscience.org/library/papers/28967885 | PubMed |
| 16 | 37049599 | Synbiotics as Supplemental Therapy for the Alleviation of Chemotherapy-Associated Symptoms in Patients with Solid Tumours. | Nutrients | 2023 | https://conductscience.org/library/papers/37049599 | PubMed |
| 17 | 29754777 | International validation of the consensus Immunoscore for the classification of colon cancer: a prognostic and accuracy study. | Lancet | 2018 | https://conductscience.org/library/papers/29754777 | PubMed |
| 18 | 39047732 | Gut microbiome model predicts response to neoadjuvant immunotherapy plus chemoradiotherapy in rectal cancer. | Med | 2024 | https://conductscience.org/library/papers/39047732 | PubMed |
| 19 | 30803449 | Impact of the gut microbiome on the genome and epigenome of colon epithelial cells: contributions to colorectal cancer development. | Genome Med | 2019 | https://conductscience.org/library/papers/30803449 | PubMed |
| 20 | 39351241 | Metabolic mediators: microbial-derived metabolites as key regulators of anti-tumor immunity, immunotherapy, and chemotherapy. | Front Immunol | 2024 | https://conductscience.org/library/papers/39351241 | PubMed |
Cited by4
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 2 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42889500 | Research progress in intratumoral microbiota: unlocking the potential of cancer immunotherapy. | Front Immunol | 2026 | https://conductscience.org/library/papers/42889500 | PubMed |
| 42828116 | Colorectal Cancer: Epidemiology, Risk Factors, Signaling Pathways, Clinical Features, Screening, Diagnosis, and Management. | MedComm (2020) | 2026 | https://conductscience.org/library/papers/42828116 | PubMed |
| 42769587 | Interkingdom microbiome physiology in colorectal cancer: barrier dysfunction, immune-metabolic signaling, and therapeutic resistance. | Front Physiol | 2026 | https://conductscience.org/library/papers/42769587 | PubMed |
| 42279452 | Microbiomics: Novel Biomarkers of Colorectal Cancer Diagnosis and Prognosis. | Diagnostics (Basel) | 2026 | https://conductscience.org/library/papers/42279452 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/41511706
GET https://conductscience.org/api/papers/v1/41511706/references?page=2